U.S. Entertainment Stock News

Ormat Technologies (NYSE:ORA) has priced $875 million of convertible senior notes in a significantly upsized offering. The company plans to use the proceeds to repurchase existing debt and shares, reshaping its capital structure. The transaction introduces new convertible securities that can affect future dilution and interest costs for shareholders. For readers tracking NYSE:ORA, this financing move comes with the stock at $110.52 and a 1 year return of 54.2%. Over 3 and 5 years, returns...

Edwards Lifesciences (NYSE:EW) has appointed Niranjan Pai as Director, Government Affairs. The new appointment places an experienced policy professional in a role focused on public policy and regulatory engagement. For investors tracking Edwards Lifesciences at a share price of $82.46, this move adds another piece to the broader picture around NYSE:EW. The company’s 1 year return of 16.2% sits alongside more modest 3 year and 5 year returns of 3.7% and 2.4%, which may prompt readers to pay...

Village Farms International reported fourth-quarter 2025 sales of US$49.62 million and net income of US$2.43 million, alongside full-year 2025 sales of US$215.94 million and net income of US$32.44 million, marking a shift from losses a year earlier. Over the same period, the company completed a repurchase of 812,923 shares for US$2.98 million, which, combined with the earnings turnaround, highlights management’s emphasis on improving profitability while also returning capital to...

ESAB Corporation (NYSE:ESAB) has priced a US$1b senior notes offering to fund the acquisition of Eddyfi Holding Inc. The deal is structured as a debt financed transaction, with the notes backed by guarantees from ESAB subsidiaries. This move follows a period of slower organic sales growth and reflects management’s focus on acquisitions to support expansion. ESAB, known for welding, cutting and gas control equipment, is moving to add Eddyfi’s testing and inspection capabilities to its...

W.W. Grainger (NYSE:GWW) has been named one of the 2026 World's Most Ethical Companies by Ethisphere. This is Grainger's second consecutive year receiving the recognition. The award highlights the company's focus on corporate governance, ethics, and responsible business practices. For investors following NYSE:GWW, this recognition comes on top of its role as a major distributor of maintenance, repair, and operating products to businesses and institutions. Ethical credentials can be...

Event context and recent share performance TEGNA (TGNA) shares recently closed at US$20.03, with the stock showing a roughly 1.3% decline over the past day, a 0.9% decline over the past week, and a 4.1% decline over the past month. See our latest analysis for TEGNA. While the recent 1 month share price return of a 4.1% decline has cooled momentum, the 1 year total shareholder return of 9.5% and 3 year total shareholder return of 39.5% point to a stronger longer term record. If you are...

Wondering whether SkyWest's current share price reflects its true value, or if the market is mispricing the stock. SkyWest recently closed at US$89.36, with a 0.2% decline over 7 days, a 16.8% decline over 30 days, an 11.7% decline year to date, a 1.1% decline over 1 year, a very large gain over 3 years and a 66.0% gain over 5 years, which may have caught your attention. Recent price moves sit against a backdrop where investors are reassessing airlines and regional carriers in light of...

CytomX Therapeutics recently reported full-year 2025 results showing sales of US$76.2 million and a net loss of US$17.37 million, and has just raised roughly US$250.00 million through a follow-on offering of common stock and pre-funded warrants at about US$5.30 per security. At the same time, the company released encouraging Phase 1 data for its EpCAM-targeted ADC Varseta-M in heavily pretreated metastatic colorectal cancer, with a high disease control rate and a safety profile that appears...

Titan America (NYSE:TTAM) has agreed to acquire Keystone Cement, expanding its presence and capacity in the Mid-Atlantic region. The company reports record revenue, EBITDA and operating cash flows for 2025, despite sector headwinds. These developments have not yet been widely discussed and may reshape Titan America's growth profile and operational footprint. For investors tracking NYSE:TTAM, the stock last closed at $14.71, with a 1 year return of 15.1% and a 12.0% decline year to date...

Why Protalix BioTherapeutics is Back on Investors’ Radar Protalix BioTherapeutics (PLX) has drawn fresh attention after the European Commission approved a new Elfabrio dosing regimen for certain Fabry disease patients, alongside updated 2026 revenue guidance that includes a US$25 million regulatory milestone. See our latest analysis for Protalix BioTherapeutics. The Elfabrio dosing news and 2026 guidance update arrive after a mixed share price pattern, with a 28.9% 90 day share price return...

For investors considering whether Vornado Realty Trust at around US$26.48 reflects enough potential or already embeds too much optimism, this article breaks down what the current share price really represents. The stock has had a mixed run, with a 1.7% gain over the last 7 days, an 8.8% decline over the last 30 days, a 20.8% decline year to date, a 29.9% decline over 1 year, and a 114.6% return over 3 years, compared with a 32.1% decline over 5 years. Recent coverage around Vornado Realty...

Ovid Therapeutics (OVID) has drawn fresh attention after reporting Phase 1 data for its OV329 epilepsy program at a 7 mg dose, alongside plans to expand into new seizure indications backed by about US$60 million in private financing. See our latest analysis for Ovid Therapeutics. The new OV329 data and US$60 million financing arrive after a sharp run in the stock, with a 30 day share price return of 60.84% and a 1 year total shareholder return above 400%, even though the 3 year and 5 year...

Collegium Pharmaceutical (NasdaqGS:COLL) has entered into a definitive agreement to acquire AZSTARYS. The deal expands Collegium’s ADHD portfolio and secures longer-term product exclusivity for its ADHD offerings. The transaction is described as immediately accretive to adjusted EBITDA. For investors following the ADHD treatment space, this move provides another data point on how branded therapies are being repositioned. Collegium, which focuses on pain and ADHD treatments, is adding...

If you are wondering whether NBT Bancorp at around US$40.97 is starting to look interesting, the current share price and fundamentals raise some clear valuation questions worth unpacking. The stock has seen a 0.7% decline over the last week, a 10.4% decline over the past month, and a 1.5% decline year to date, while the 1 year, 3 year, and 5 year returns stand at a 1.9% decline, 34.7%, and 21.3% respectively. Recent attention on regional banks, regulatory capital expectations, and investor...

Globant (NYSE:GLOB) announced an AI focused collaboration with PharmaMar to support cancer drug discovery efforts. The company also agreed a global integration partnership with payments platform Adyen for enterprise clients. Both arrangements position Globant in healthcare and fintech projects tied to drug research and digital payments infrastructure. Globant operates as a digital services and technology company, working with enterprises that are investing in cloud, data and AI based...

Intuitive Machines (LUNR) closed FY 2025 with Q4 revenue of US$44.8 million and a basic EPS loss of US$0.17, alongside a net loss of US$19.9 million, while on a trailing 12 month basis revenue was US$210.1 million and EPS stood at a loss of US$0.71 with a net loss of US$83.9 million. Over recent quarters, the company has seen quarterly revenue move from US$62.5 million in Q1 2025 to US$50.3 million in Q2, US$52.4 million in Q3 and US$44.8 million in Q4, with EPS losses ranging between US$0.06...

United States Antimony (NYSE:UAMY) secured a U.S. government contract worth more than $248m for antimony ingots in the past week. The company reported an additional $354m in new antimony agreements, expanding its role in critical mineral supply chains. UAMY announced an acquisition of a tungsten asset in Ontario, targeting domestic tungsten production for North America. The company restarted antimony mining in Montana and is increasing processing capacity with active government...

CONMED (NYSE:CNMD) has exited the gastroenterology market and transferred global distribution rights for certain product lines to Micro-Tech Endoscopy. The company has also appointed Andrew Moller as Interim Chief Financial Officer. For investors watching NYSE:CNMD, these moves come at a time when the share price is around $36.8 and multi year returns have been weak, with the stock down 37.1% over 1 year, 60.8% over 3 years, and 69.5% over 5 years. Stepping away from gastroenterology...

Red Cat Holdings (RCAT) has wrapped up FY 2025 with fourth quarter revenue of about US$26.2 million and a basic EPS loss of US$0.16, alongside trailing twelve month revenue of roughly US$40.7 million and a TTM basic EPS loss of US$0.73. Over the past five reported quarters, the company has seen quarterly revenue range from about US$1.3 million to US$26.2 million. Over the same period, quarterly basic EPS has stayed in loss-making territory between roughly US$0.15 and US$0.33 per share,...

Investors may be wondering whether Wolverine World Wide at US$16.50 still offers value after a strong rebound, or if the easy gains are already behind it. The stock has returned 22.2% over the last year, although the year-to-date return sits at a 9.4% decline, with a 2.4% gain over the last week and an 8.9% decline over the last month. Recent attention on Wolverine World Wide has focused on its brand portfolio, cost structure and balance sheet, as investors weigh how these factors might...

Consolidated Water Co. Ltd. has reported full-year 2025 results, with sales of US$132.07 million versus US$133.97 million a year earlier and net income of US$18.34 million versus US$28.24 million, reflecting softer overall profitability. Despite lower total net income and earnings per share, the company’s earnings per share from continuing operations edged higher, highlighting a relatively stronger performance in its ongoing core businesses. We’ll now examine how the lower full-year net...

Alliant Energy filed a $1b at-the-market equity offering program, signaling a sizeable new capital raise. The program allows the company to issue new shares over time into the open market rather than in a single offering. This move comes as Alliant Energy (NasdaqGS:LNT) continues to invest around large data center customers and recent expansion initiatives. Alliant Energy (NasdaqGS:LNT) is coming off a period where the share price is $71.32 and the stock is up 8.7% year to date and 15.8%...

In its latest quarterly report, CRA International posted an 11.6% year-over-year revenue increase, beating analyst forecasts and marking its eighth consecutive annual revenue record, alongside full-year guidance that also exceeded expectations. This combination of stronger-than-anticipated current performance and higher forward revenue guidance highlights how CRA International is currently converting demand for its consulting expertise into sustained top-line momentum. Next, we'll explore...

ABM Industries (NYSE:ABM) has completed its acquisition of WGNSTAR, a provider of services to semiconductor facilities. The deal expands ABM's footprint in semiconductor fabrication plants and related industrial sites tied to US chip and industrial supply chains. The acquisition will influence ABM's exposure to chip production facilities and data center related demand over time. ABM Industries is known for facility services across commercial, industrial and technology end markets. WGNSTAR...